Treatment of Immune Thrombocytopenia (ITP)

Posted On 2021-04-14 17:43:24


This Series on “Treatment of Immune Thrombocytopenia (ITP)” is edited by Prof. John W. Semple and Dr. Rick Kapur from Lund University, Lund, Sweden and University of Amsterdam, Amsterdam, The Netherlands.

Editorial on Treatment of Immune Thrombocytopenia (ITP)
Focused themed issue on immune thrombocytopenia (ITP)
John W. Semple, Rick Kapur

Review Article on Treatment of Immune Thrombocytopenia (ITP)
Efficacy and mechanism of intravenous immunoglobulin treatment for immune thrombocytopenia in adults
Ruqayyah J. Almizraq, Donald R. Branch

Intravenous immunoglobulins (IVIg) in childhood immune thrombocytopenia: towards personalized medicine—a narrative review
David E. Schmidt, Katja M. J. Heitink-Pollé, Marrie C. A. Bruin, Masja de Haas

Pediatric immune thrombocytopenia (ITP) treatment
Taylor Olmsted Kim, Jenny M. Despotovic

Management of immune thrombocytopenia in pregnancy
Jacqueline N. Poston, Terry B. Gernsheimer

FcRn antagonists in ITP
Adrian C. Newland, Vickie McDonald

The treatment of immune thrombocytopenia (ITP)—focus on thrombopoietin receptor agonists
David J. Kuter

Novel insights in medical management of immune thrombocytopenia
Moghees Hanif, Suthesh Sivapalaratnam, Drew Provan

Immune thrombocytopenia: the patient’s perspective
Caroline Kruse, Alexandra Kruse, Jennifer DiRaimo

Disclosure:
The focused issue “Treatment of Immune Thrombocytopenia” was commissioned by the editorial office, Annals of Blood without any sponsorship or funding. John W. Semple and Rick Kapur served as the unpaid Guest Editors for the focused issue.